August 29, 2016 8:41 PM ET

Pharmaceuticals

Company Overview of Genzyme Oncology, Inc.

Company Overview

As of June 2011, Genzyme Oncology, Inc. was acquired by Sanofi. Genzyme Oncology, Inc. focuses on developing and commercializing treatments for cancer patients. Its products are focused on the treatment of leukemia, lymphoma, and stem cell transplant. The company offers Campath, a recombinant DNA-derived humanized monoclonal antibody for the treatment of B-cell chronic lymphocytic leukemia; Clolar and Fludara that are purine nucleoside anti-metabolites for the treatment of pediatric patients with relapsed or refractory acute lymphoblastic leukemia; Leukine, a recombinant yeast derived human granulocyte macrophage colony-stimulating factor for adult patients with acute myelogenous leukemia; a...

55 Cambridge Parkway

Cambridge, MA 02142

United States

Founded in 1994

5,600 Employees

Phone:

617-761-8777

Fax:

617-761-8918

Key Executives for Genzyme Oncology, Inc.

Genzyme Oncology, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genzyme Oncology, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.